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TIMPsThe incidence of heart failure (HF) increases with age. This study sought to determine whether aging exacer-
bates structural and functional remodeling of the myocardium in HF. HF was induced in young (~18 months)
and aged sheep (>8 years) by right ventricular tachypacing. In non-paced animals, aging was associated with
increased left ventricular (LV) end diastolic internal dimensions (EDID, Pb0.001), reduced fractional shorten-
ing (Pb0.01) and an increase in myocardial collagen content (Pb0.01). HF increased EDID and reduced frac-
tional shortening in both young and aged animals, although these changes were more pronounced in the
aged (Pb0.05). Age-associated differences in cardiac extracellular matrix (ECM) remodeling occurred in HF
with collagen accumulation in young HF (Pb0.001) and depletion in aged HF (Pb0.05). MMP-2 activity in-
creased in the aged control and young HF groups (Pb0.05). Reduced tissue inhibitor of metalloproteinase
(TIMP) expression (TIMPs 3 and 4, Pb0.05) was present only in the aged HF group. Secreted protein acidic
and rich in cysteine (SPARC) was increased in aged hearts compared to young controls (Pb0.05) while
serum procollagen type I C-pro peptide (PICP) was increased in both young failing (Pb0.05) and aged failing
(Pb0.01) animals. In conclusion, collagen content of the cardiac ECM changes in both aging and HF although;
whether collagen accumulation or depletion occurs depends on age. Changes in TIMP expression in aged fail-
ing hearts alongside augmented collagen synthesis in HF provide a potential mechanism for the age-
dependent ECM remodeling. Aging should therefore be considered an important factor when elucidating car-
diac disease mechanisms.
© 2012 Elsevier Ltd. Open access under CC BY license. 1. Introduction
Heart failure (HF) is predominantly a disease of the elderly [1]which
results in structural and functional remodeling of the myocardium. Al-
terations to the properties of the cardiac extracellular matrix (ECM),
which consists of predominantly ﬁbrillar collagen [2], are central to
this remodeling process e.g. [3,4]. The cardiac ECM serves to maintain
correct myocyte geometry and cardiac extension properties, and pro-
vides tensile strength to the tissue. As such it can directly alter both
the systolic and diastolic function of the heart [5] even in the absence
of myocyte contractile dysfunction [6] with the collagen type III:I ratio
inversely correlatingwith ventricular function [7]. As a general rule col-
lagen accumulation, or interstitial ﬁbrosis, results in ventricular stiffen-
ing and reduced compliance of the myocardium [8], whereas collagen
loss promotes myocyte slippage and ventricular dilatation [3,9].
Maintenance of ECM homeostasis is achieved through a balance be-
tween collagen synthesis and degradation. Thematrixmetalloproteinases: +44 161 275 2703.
uk (A.W. Trafford).
 license. (MMPs) are the key enzymes responsible for ECM degradation whereas
the tissue inhibitors of metalloproteinases (TIMPs) endogenously inhibit
this process. Although it is known that remodeling of the myocardial
ECM occurs in HF, a consensus on the nature of these alterations does
not exist, with some evidence favoring ﬁbrosis at the point of end-stage
HF [10–12], and others depicting collagen depletion [13–15]. This is likely
reﬂective of the animal model used, underlying pathological process as
well as changes to the balance between collagen synthesis and degrada-
tion [3,4,11,13].
It has been commonly observed that in aging, ﬁbrosis leads to
increased passive stiffness of the myocardium and impaired diastol-
ic function e.g. [16,17] and the MMP and TIMP proﬁle prior to the
onset of cardiac disease can dramatically alter the response of the
ECM to injury [18–21]. Therefore, the changes to the myocardial
MMP–TIMP proﬁle and the consequent effects on myocardial colla-
gen content that occur in aging [22], are likely to have a profound
inﬂuence on the outcome of ECM remodeling occurring in response
to cardiac insult. However, as the majority of studies have been car-
ried out using young animal models of HF, the mechanism of dis-
ease progression on an aging substrate has not yet been
addressed. Crucially, the role of the ECM in the pathogenesis of
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sent study, we have employed a large animal model of ventricular
tachypacing, in order to investigate whether and to what extent aging
alters the response of the cardiac ECM in the development of HF. The
ﬁndings from this study suggest that the response of the myocardial
ECM to rapid pacing-induced HF is highly dependent on age.2. Methods
An expanded methods section is provided in the online supple-
mentary material.
All procedures involving the use of animals were performed in ac-
cordance with The United Kingdom Animals (Scientiﬁc Procedures)
Act, 1986 and conform to the Guide for the Care and Use of Laboratory
Animals published by the US National Institutes of Health (NIH Publi-
cation No. 85-23, revised 1996).2.1. Experimental model of aging and heart failure
HFwas induced in 25 femaleWelshMountain sheep (37.4±1.2 kg)
aged either 18–24 months (young) or >8 years (aged, last quintile of
normal life expectancy [23]) by 31.8±0.9 days of right ventricular
tachypacing at 210 beats min−1 using a method described previously
[24,25]. Following tachypacing, ﬁnal in vivomeasurements were made
and then animals were killed (heparin 10,000 units and pentobarbitone
sodium 200 mg kg−1 intravenously).2.2. Echocardiography and blood pressure
Cardiac geometry and contractility were assessed by trans-thoracic
echocardiography performed on conscious, supine animals as described
previously [24,25]. Indirect blood pressure (BP) measurements were
made from the coccygeal artery using tail cuff plethysmography in
standing animals (Cardell, Sharn USA).2.3. Histological assessment of collagen content
For histological analysis of collagen content, full-thickness sec-
tions of the left ventricular (LV) free wall were stained with picrosir-
ius red (PSR) and interstitial collagen visualized using polarized light
microscopy as described previously [3]. Collagen content is expressed
as percentage collagen-containing pixels per tissue section area [3].2.4. Gelatin zymography
LV tissue was snap frozen in liquid nitrogen and gelatin zymogra-
phy performed as described previously [3]. Protein samples (20 μg)
were separated using non-reducing SDS-PAGE containing 1 mg ml−1
gelatin. Each sample was repeated in triplicate and zymographic
band intensity normalized to an internal standard common to each
gel (prepared from LV tissue from a non-experimental young control
animal). Conﬁrmation that lytic bands were produced by MMPs was
performed by incubating a parallel zymogram in incubation buffer
containing EDTA (10 mmol l−1). The EDTA chelates the calcium nec-
essary for MMP activity and thus inhibits gelatinase-dependent gela-
tin degradation. Differentiation between pro- and active MMPs was
carried out using a p-aminophenylmercuric acetate (APMA,
10 mmol l−1) activation assay as previously described [3]. Brieﬂy,
the APMA will activate any MMPs present in their pro-form using
HT-1080 conditionedmedia (a source of MMPs 2 and 9 [26]) as a pos-
itive control. If theMMP present is already in its active form, no shift in
band weight will occur upon incubation with APMA compared to
without APMA.2.5. Immunoblotting
TIMP-1, 2, 3, and 4 as well as secreted protein acidic and rich in
cysteine (SPARC) protein levels were measured by immunoblotting.
LV protein extracts were prepared as described previously [3,27,28].
Samples were separated by reducing SDS-PAGE before transferring
to nitrocellulose membranes. Details of immunoblotting conditions
are described in Supplementary Material Table 1. Each sample was re-
peated in triplicate and protein levels normalized to an internal stan-
dard common to each blot (LV tissue from a non-experimental young
control animal). In preliminary studies we found that the expression
levels of the so-called ‘housekeeping’ proteins β-actin and glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH) are altered in aging and
HF [24] (data not shown). However, following transfer to nitrocellu-
lose, all blots are stained with Ponceau-S to ensure even gel loading
and transfer (data not shown).2.6. qPCR
cDNA was prepared from 1 μg total RNA isolated from sheep LV
using Invitrogen Superscript III (Life Technologies, California). Ovis
aries type I collagen-α precursor (Col1A1) mRNA expression was
measured using an Applied Biosystems StepOnePlus™ real-time ma-
chine (Life Technologies, California) and primer sequences obtained
from Jarvis et al. [29]. mRNA expression was measured using Applied
Biosystems Power SYBR Green PCR Mastermix ﬂuorescent incorpora-
tion (Life Technologies, California) and normalized to ribosomal 28S
housekeeping gene.2.7. Biochemical measurement of collagen ﬁbril formation
Venous blood samples were collected from the jugular vein in ex-
perimental animals both pre-pacing and at the point of HF. Samples
were spun at 4000×g for 10 min to obtain serum. Serum was snap-
frozen and stored in liquid nitrogen. Procollagen type I carboxy-
terminal pro peptide (PICP) was measured from sheep serum using
a speciﬁc ELISA according to the manufacturer's instructions (Takara
Bio Inc, Japan). Serum PICP concentration was quantiﬁed from dupli-
cate samples versus a standard curve constructed using PICP stan-
dards. The minimum detection level for the assay was 10 ng/ml.2.8. Data analysis
Data obtained from in vivomeasurements, as well as quantiﬁcation
of serum PICP levels, were from the same animal and are therefore
paired data sets i.e. before tachypacing and at the point of HF. Assess-
ments of collagen content, MMPs, TIMPs, SPARC and collagen type I
mRNA required the used of post mortem myocardial tissue samples,
and were therefore obtained from separate sets of control young and
control aged animals. All data is represented as mean±standard error
of the mean (SEM) of n animals. Unpaired data was assessed using a
2-way analysis of variance (ANOVA) whereas paired data were ana-
lyzed using a 2-way repeated measures ANOVA. Data that was not nor-
mally distributed was transformed by means appropriate to the spread
of data (square or reciprocal) prior to statistical analyses. Correlations
between linear regressions were performed using Pearson's coefﬁcient.
Differences were considered signiﬁcant at Pb0.05.3. Results
Following tachypacing, both young and aged animals displayed
clinical symptoms of biventricular failure including dyspnea and asci-
tes and pulmonary edema.
Fig. 1. Impaired contractility and ventricular dilatation in aging and heart failure. Representative m-mode echocardiograms taken proximal to the papillary muscle from young pre-
paced, young failing, old pre-paced, and old failing animals. Open arrow, septum endocardial surface; and solid arrow, left ventricular free wall endocardial surface.
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dysfunction in heart failure
Trans-thoracic echocardiography was performed on 15 young and
10 aged animals prior to implantation of cardiac pacemakers (pre-
pacing) and following tachypacing-induced HF (post-pacing). Due
to the anatomical arrangement of the cardiac apex over the sternum
in the sheep, trans-thoracic four-chamber apical views were unob-
tainable, thus precluding measurement of cardiac mass, volumes
and ejection fraction. Instead, measurements were made from right-
sided parasternal long-axis and short-axis views. Representative m-
mode echocardiograms are illustrated in Fig. 1 and the data is sum-
marized in Table 1.
Of particular note, LV end diastolic internal dimension (EDID) was
increased by 32±9.9% in aging (Pb0.001) while fractional shortening
assessed from long-axis m-mode echocardiograms was reduced by
14±3.8% (Pb0.01). Similarly, the fractional area change obtained
from short-axis coronal views at the level of the papillary muscle tip
also showed a 14±2.8% reduction in aging (Pb0.05). In addition to
changes in LV function and geometry, aging also resulted in a 7.6±
3.4 mmHg increase in diastolic BP and 7.2±3.3 mmHg rise in mean
arterial pressure (both Pb0.05).
Tachypacing in young animals resulted in a 61±10.6% increase in
EDID and a 55±2.4% decrease in fractional shortening (both Pb0.001)
and aged tachypaced animals displayed a 29±10.1% increase in EDID
and a 62±4.7% decrease in fractional shortening (both Pb0.001). LV
chamber diameter and contractile dysfunction were greatest in aged an-
imals following tachypacing (both Pb0.05). Fractional area change was
reduced with tachypacing in young and aged animals by 46±5.2% and
46±5.2%, respectively (both Pb0.001). In addition, tachypacing led toTable 1
Echocardiographic and hemodynamic measurements.
Young (n=15)
Pre-paced Post-paced Δ (%)
EDID (cm) 2.5±0.12 3.8±0.07*** 61.1±
ESID (cm) 0.8±0.07 2.7±0.09*** 248.1
Fractional shortening 0.7±0.02 0.3±0.02*** −55.
RWT 1.0±0.10 0.4±0.03*** −49.
Fractional area change 0.7±0.02 0.4±0.02*** −42.
Systolic BP (mmHg) 125.8±2.6 111.0±2.7*** −11.
Diastolic BP (mmHg) 78.5±1.9 69.0±1.4*** −11.
Mean BP (mmHg) 94.3±2.0 83.0±1.7*** −11.
Values are mean±SEM. *Pb0.05 vs. young pre-paced. **Pb0.01 vs. young pre-paced. ***Pb
#Pb0.05 vs. young post-paced. ##Pb0.01 vs. young post-paced. EDID, end diastolic intern
(EDID subtract ESID) divided by EDID. RWT (relative wall thickness) calculated as (2× diast
area subtract end systolic area) divided by end diastolic area. BP, blood pressure.similar decreases in systolic, diastolic and mean BP in both young and
aged animals (all Pb0.001).
3.2. Alterations to LV collagen content in heart failure are age-dependent
The interstitial LV collagen matrix was assessed using histological
methods, which, unlike biochemical techniques, enables the exclusion
of non-interstitial collagen (epicardial, endocardial and perivascular).
Tissue sections visualized by light microscopy revealed an extensive
collagen network in the ovine LV and demonstrated that interstitial
ﬁbrosis was evident in both aging and after tachypacing in young
animals (Fig. 2A, arrows). Conversely, the collagen networkwasmark-
edly depleted in aged tachypaced animals (Fig. 2Aiv/viii).
Mean interstitial collagen content was quantiﬁed as the non-
vascular myocardial collagen and therefore also excluded endocardial
and epicardial regions, and expressed as percentage collagen-
containing pixels per tissue section area (Fig. 2B) [3]. Aging resulted
in increased collagen content compared to young controls (2.3±
0.4% vs. 1.0±0.14%, n=5, Pb0.01). Conversely, a divergent response
of thematrix occurred following tachypacing,with collagen accumulation
in the youngHF group (2.6±0.28% vs. 1.0±0.14%, n=5–8, Pb0.001) and
collagen loss in the aged HF group (1.2±0.25% vs. 2.3±0.4%, n=5–6,
Pb0.05). Importantly, the collagen content in the aged HF myocardium
was also less than that in the young HF animals (Pb0.01).
The relationship between myocardial collagen content, LV diastol-
ic dimensions and fractional shortening is shown in Figs. 2C and D.
Again, there is an age-dependent divergent response to tachypacing.
With the induction of HF, chamber dilatation and reduced fractional
shortening occur in parallel to increased collagen content in the
young (Fig. 2C) and decreased collagen content in the aged (Fig. 2D).Aged (n=10)
Pre-paced Post-paced Δ (%)
10.6 3.3±0.19*** 4.2±0.13†††,# 29.2±10.1
±26.9 1.4±0.15** 3.3±0.19†††,## 156.1±28.1
2±2.4 0.6±0.02** 0.2±0.02†††,# −62.0±4.7
7±6.3 0.7±0.08 0.5±0.07†† −34.4±5.6
1±4.3 0.6±0.01* 0.3±0.03††† −45.5±5.2
7±1.8 132.2±2.6 116.9±2.9††† −11.4±2.2
6±2.9 86.1±2.8* 71.3±3.2††† −17.1±2.6
7±2.3 101.5±2.6* 86.5±2.7††† −14.7±1.8
0.001 vs. young pre-paced. ††Pb0.01 vs. old pre-paced. †††Pb0.001 vs. old pre-paced.
al diameter. ESID, end systolic internal diameter. Fractional shortening calculated as
olic wall thickness) divided by EDID. Fractional area change calculated as (end diastolic
Fig. 2. Age-associated differences in remodeling of the collagen matrix in heart failure. (A) Representative picrosirius red (PSR) stained micrographs imaged at ×20 magniﬁcation in
bright ﬁeld (Ai–iv) and circularly polarized light (Av–viii) from young control (YC: Ai, Av), young failing (YF: Aii, Avi), old control (OC: Aiii, Avii) and old failing (OF: Aiv, viii) an-
imals. Pixels positive for collagen appear red/yellow/green in the polarized images (arrows). (B) Collagen content determined from histological sections expressed as mean±SEM
of n=YC=5, YF=8, OC=5 and OF=6. The relationship between collagen content and ventricular shape and function is depicted for (C) young, and (D) aged animals. Data points
are mean±SEM for n of YC=5 (collagen) and 15 (echo), YF=8 (collagen) and 15 (echo), OC=5 (collagen) and 10 (echo) and OF=6 (collagen) and 10 (echo). **Pb0.01 vs. YC.
***Pb0.001 vs. YC. †Pb0.05 vs. OC. ##Pb0.01vs. YF. Data symbols: open circle, YC; solid circle, YF; open triangle, OC; and solid triangle, OF. EDID, end diastolic internal dimension.
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response of the collagen matrix in heart failure
Since aging leads to a differential response of the collagen matrix
to tachypacing-induced HF, the next series of experiments were car-
ried out to investigate whether the regulation of ECM turnover in
HF is inﬂuenced by age. MMP activity in ventricular tissue was
assessed using gelatin zymography. Fig. 3Ai shows a representative
zymogram illustrating gelatinolytic activity at ~68 kDa correspondingto MMP-2 (commercial standard not shown). No additional gelatino-
lytic activity was seen at other molecular weights suggesting that
MMP-2 is the major gelatinase involved in the LV remodeling re-
sponse in the sheep. This was conﬁrmed by running LV extracts
alongside ovine lung tissue as a positive control which shows the
presence of MMP-9 (see Supplementary Fig. 3). Gelatinolytic activity
due to MMP-2 was abolished by pre-incubation with EDTA
(10 mmol l−1, Fig. 3Aii). Fig. 3B demonstrates that the gelatinolytic
activity of MMP-2 was due to the active rather than the pro-form of
Fig. 3.MMP-2 activity is elevated in aging and heart failure. (A) Representative gelatin
zymograms (i) from YC, YF, OC and OF LV protein extracts. (ii) Gelatinolytic activity
was conﬁrmed by incubating a parallel gel with EDTA. (B) Zymogram of HT-1080 con-
ditioned media (gray bar) and LV extracts from YC (open bar), YF (striped bar) and OC
(solid bar) pre-incubated in the presence (+) or absence (−) of p-
aminophenylmercuric acetate (APMA). (C) MMP-2 activity quantiﬁed by densitometry
and expressed as mean pixel density (relative to an internal standard — LV tissue from
a young control sheep not used in the current study)±SEM of n=YC=7, YF=7,
OC=8 and OF=6. *Pb0.05 vs. YC. **Pb0.01 vs. YC.
Fig. 4. TIMPs 3 and 4 are reduced only in aged animals with heart failure. (A) Representativ
tracts. Protein levels were quantiﬁed by densitometry for TIMP-1 (B), TIMP-2 (C), TIMP-3 (
OF=6 (n=10 for TIMP-3). †Pb0.05 vs. OC. #Pb0.05 vs. YF. ##Pb0.01 vs. YF.
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duce a shift in band weights in ovine LV extracts, despite activation
of pro-MMP-2 in the HT-1080 conditioned media. Gelatinase activity
was also the same molecular weight as MMP-2 in the HT-1080 condi-
tioned media positive control.
Summary data for MMP-2 activity is presented in Fig. 3C and
expressed as a ratio to an internal standard. Compared to the young
control animals, MMP-2 activity was increased in both the young HF
(1.7±0.14 vs. 1.0±0.22, n=7, Pb0.01) and aged control myocardi-
um (1.5±0.08 vs. 1.0±0.22, n=7–8, Pb0.05). However, there was
no further augmentation of MMP-2 activity in the aged HF samples.3.4. Reduced TIMP expression is present only in aged failing hearts
The age- and disease-dependent alterations to total MMP activity are
therefore inconsistent with the changes to myocardial collagen content
occurring in aging andHF. The next series of experiments sought to deter-
mine if the levels of TIMPs (which regulateMMP activity)were altered by
aging and/or disease and if this provides amechanism for the preferential
accumulation of collagen in the young HF animals and loss of collagen in
the agedHF animals. Fig. 4A shows representative immunoblots for TIMP-
1, 2, 3 and 4 levels. By two-way ANOVA, no differences in TIMP-1 (Fig. 4B)
or TIMP-2 (Fig. 4C) were evident in either aging or HF. However, both
TIMP-3 (Fig. 4D; aged HF, 1.1±0.04; aged control 1.5±0.12; young HF,
1.5±0.16; young control, 1.7±0.3. n=5–10) and TIMP-4 (Fig. 4E; aged
HF, 1.1±0.06, aged control, 1.8±0.15; young HF, 2.3±0.26; young con-
trol 1.9±0.2. n=5–8) levels were reduced only in the aged failing myo-
cardium (Pb0.05).e Western blots for TIMP-1, TIMP-2, TIMP-3 and TIMP-4 from YC, YF, OC and OF LV ex-
D) and TIMP-4 (E). Data is expressed as mean±SEM of n=YC=5, YF=8, OC=5 and
Fig. 5. Relationship between TIMP protein levels and MMP-2 activity. (A) Correlation
between MMP-2 activity and TIMP-3 protein was not signiﬁcant. (B) Elevated MMP-
2 activity was signiﬁcantly correlated with a decrease in TIMP-4 protein. Closed sym-
bols represent paired data points from n of YC=3 (4 for TIMP-4), YF=2, OC=3 and
OF=6; open symbols represent mean values from each experimental group where n
of YC=7 (MMP) and 5 (TIMP), YF=7 (MMP) and 8 (TIMP), OC=8 (MMP) and 5
(TIMP) and OF=6 (MMP) and 10 (TIMP-3; 6 for TIMP-4). Circle = YC, square = YF,
upwards triangle = OC and downwards triangle = OF. Regression lines have been ﬁt
to all data points.
Fig. 6. Collagen deposition and processing is altered in aging and heart failure. (Ai) Agarose
verse transcriptase; ±, with reverse transcriptase). (ii) Collagen type I mRNA measured us
OC=5 and OF=6. (B) Representative immunoblot for SPARC extracted from LV tissue samp
standard. n=6 per group. (C) Procollagen type I C-peptide was quantiﬁed from sheep seru
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TIMP-4 protein inversely correlates with the augmented MMP-2 activ-
ity measured by zymography. These relationships are depicted in
Fig. 5. Despite the reduction of TIMP-3 in the aged HF myocardium,
this was not correlated with increased MMP-2 activity (Fig. 5A:
slope=−0.234±0.15, n=14, P=0.138). Conversely, a signiﬁcant cor-
relation was detected between TIMP-4 levels and MMP-2 activity
(Fig. 5B: slope=−0.325±0.14, n=15, Pb0.05) in ovine myocardium.
3.5. Collagen processing and ﬁbrillogenesis is altered in aging and heart
failure
While diminished TIMP expression provides one mechanism by
which a reduction in collagen content may occur in the aged, failing
hearts, changes to collagen degradation pathways alone cannot explain
whymyocardial ﬁbrosis is present in young paced, and aged control an-
imals. The next set of experiments sought to determine if alterations to
collagen synthesis and/or processing may explain these changes. Al-
though qPCR data (Fig. 6A) did not reach signiﬁcance, there is a trend
towards an increase in collagen type I mRNA expression in HF versus
control in both young and aged sheep (P=0.079).
Fig. 6Bi depicts a representative immunoblot for SPARC, a
collagen-binding matricellular protein involved in post-synthetic col-
lagen processing and thus formation of mature collagen ﬁbrils
[30,31]. SPARC expression was increased in aged animals compared
to young (Fig. 6Bii: 1.6±0.37 vs. 0.9±0.17, n=6, Pb0.05), however
no change in SPARC was detected with disease. Furthermore, SPARC
levels in aged failing animals were not altered compared to aged con-
trol, or young HF (P=0.735 and P=0.191, respectively).
Finally, collagen ﬁbrillogenesis was quantiﬁed indirectly by mea-
suring the presence of PICP in sheep serum samples (Fig. 6C).
Serum PICP was increased in young HF compared to young controls
(1067±247 ng/ml vs. 465±84 ng/ml, n=6, Pb0.05) and also ingel illustrating a single product from Col1A1 primers and ovine cDNA (−, without re-
ing qPCR was not signiﬁcantly altered in aging and/or heart failure. n=YC=5, YF=5,
les is depicted in (i). (ii) Bands were quantiﬁed by densitometry relative to an internal
m using a speciﬁc ELISA assay. n=6 per group. *Pb0.05 vs. YC. ††Pb0.01 vs. OC.
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n=6, Pb0.01). PICP concentration however was not higher in aged
HF versus young HF animals (P=0.297).
4. Discussion
Remodeling of the cardiac ECM is believed to directly contribute to
the deterioration of myocardial function which occurs in HF. However,
whether aging per se inﬂuences the response of the cardiac ECM to HF
is largely unknown. The present study investigates the impact of aging
and HF on the collagen content of the cardiac ECM and has ﬁve major
ﬁndings: i) aging results in cardiac enlargement and reduced contractil-
ity, ii) tachypacing-induced HF leads to collagen accumulation in young
animals and collagen depletion in aged animals, iii) compared to young
control samples,MMP-2 activity is increased in the young HF, aged con-
trol and aged HF myocardium, iv) TIMPs 3 and 4 are decreased only in
the aged failing myocardium, and v) collagen processing and ﬁbrillo-
genesis is altered as result of aging and disease. We propose that, for a
given cardiac insult leading to the development of HF, the alteredproﬁle
of MMP activity, TIMP expression and collagen processingwhich occurs
in aging, predispose the aged heart to greater functional remodeling
and changes in collagen content in the opposite direction to those
seen in young hearts.
4.1. Cardiac remodeling in aging and heart failure
Cardiac dilatation and reduced contractile function are hallmarks
of tachycardic and dilated cardiomyopathy [32]. Due to the ovine an-
atomical arrangement whereby the cardiac apex lies directly under-
neath the sternum, we were unable to measure ventricular volumes
and thus ejection fraction. However by using parasternal long-axis
images, we have established that the above hallmarks are present in
the current ovine model of tachypacing-induced HF. Similar, albeit
far less pronounced, structural and functional remodeling also occurs
in the aged heart e.g. Lindsey et al. [22] and Sangaralingham et al. [33].
However, whether the changes in LV structure and function that
occur in aging inﬂuence the response of the myocardium to a
disease-causing insult remain very poorly understood. In a single
study of canine experimental ischemia and reperfusion, where hearts
were studied 3 days after reperfusion, aged animals demonstrated
greater infarct size and chamber dilatation than young animals [34].
While this suggests the importance ECM degradative pathways in
an aged model of ischemia-reperfusion injury, no long-term follow
up data on cardiac remodeling or HF progression was available for
this study. Conversely, in a model of myocardial ischemia in the rat,
no age-dependent changes in cardiac remodeling were noted [35].
However, in this latter study the original cardiac insult was produced
in ‘middle-aged’ (18 month old) rather than aged rats. As such the ex-
tent of myocardial remodeling present at the time of ‘injury’ may be
less than that in either the present study or that of Jugdutt et al.
[34], with consequent effects for the extent of remodeling occurring
after the injury.
4.2. Age-dependent ECM remodeling in heart failure
A striking observation in the present study is the diametrically op-
posite changes to cardiac collagen content occurring in HF in the
young and aged animals. Although in the present study collagen con-
tent was determined histologically, we and others have veriﬁed this
technique against biochemical quantiﬁcation of collagen in a previous
publications and have shown a strong correlation between the two
methodologies [3,36,37]. Changes to myocardial collagen content in
HF have been reported previously in many studies of experimental
HF with some showing an increase in myocardial collagen content
[4,38] and others a decrease at the point of symptomatic HF
[3,13,39]. Importantly however, none of these studies investigatedthe importance of aging in the response of the ECM to HF. Considering
the potential mechanisms underlying the age-dependent changes in
cardiac ECM collagen content in HF, the increase of MMP-2 activity
occurring in both aging and HF does not, by itself, provide sufﬁcient
explanation. However, the reduction of TIMP-3 and 4 that occur pref-
erentially in the aged HF samples, and explicitly the correlation be-
tween MMP-2 activity and TIMP-4 protein, provide a possible
mechanism for the speciﬁc loss of myocardial collagen in the aged
HF cohort. However, as TIMP expression was not increased in either
the young failing or aged control groups, this mechanism cannot ac-
count for the collagen accumulation which was measured in these ex-
perimental groups (Fig. 2). We used three experimental approaches
to investigate whether altered collagen processing and/or synthesis
could explain this discrepancy. An increase in SPARC in aging suggests
that the facilitation of mature collagen ﬁbril formation from procolla-
gen is enhanced in the aged myocardium, a ﬁnding which is sup-
ported by others [31]. Even though a signiﬁcant increase in collagen
type I mRNA was not established in the present model of HF, serum
levels of PICP suggest collagen synthesis is increased in both young
failing and aged failing hearts. Although this is an indirect technique
for quantifying myocardial collagen deposition, serum PICP levels
have been demonstrated to correlate with coronary sinus PICP levels
and also myocardial collagen deposition [40,41]. Importantly, the in-
crease in collagen synthesis in aged failing animals occurred to a sim-
ilar extent to that in young failing animals. Furthermore, as TIMP
expression is only reduced in the aged failing hearts, taken together
this data suggests a mechanism for the divergent age-dependent col-
lagen remodeling which occurs in this model of pacing-induced HF.
However, the observation that increased myocardial collagen in
young failing animals could lead to similar (albeit less pronounced)
symptoms of cardiac decompensation as that seen in aged failing an-
imals which displayed diminished collagen content, was surprising.
Several lines of experimental evidence give indications as to why
this might be the case. Altered collagen cross-linking has been dem-
onstrated to change systolic performance independent of total colla-
gen content [42,43], as well as changes to collagen type I:III ratio
[44]. Furthermore, modiﬁcations to the sarcomeric protein titin such
as isoform switches and/or phosphorylation status would also inﬂu-
ence passive stiffness and thus contractile function [45]. Further stud-
ies would be required to establish whether age-dependent changes in
these factors are inﬂuencing functional and morphological changes
demonstrated in this ovine model of HF.
4.3. Aging as a pathological mechanism for divergent ECM remodeling in
heart failure
A key question regarding the divergent remodeling of the cardiac
ECM that occurs in aging in response to tachypacing-induced HF relates
to whether or not pre-existent alterations to the biochemical ﬁngerprint
of the agedmyocardium facilitate these differential effects. Studies using
transgenic and knockout mouse models suggest this is likely. For exam-
ple, ablation of cardiac MMP-2 or MMP-9 attenuates cardiac remodeling
post myocardial ischemia [21,46]. Conversely, knockout of each of the
cardiac TIMPs (1–4) accelerates adverse cardiac remodeling after injury
[18–20,47] — a phenotype which, in the case of TIMP-4, was rescued
with a double knockout involving MMP-2 deletion [19]. Additionally,
TIMP-4 knockout mice displayed reduced cardiac function at 20 months
of age whereas young TIMP-4 knockouts had comparable echocardio-
graphic parameters to age-matched wild-type littermates [19]. These
data, together with the fact that TIMP-4 is the most prevalent TIMP in
the myocardium, and serves to regulate MMP-2 activity with high afﬁn-
ity [48,49], provide additional evidence that superimposition of dimin-
ished TIMP-4 expression in the aged, failing myocardium could lead to
enhanced ECM remodeling through loss of MMP-2 inhibition leading to
cardiac dysfunction. Furthermore, as SPARC has been demonstrated to
enhance MMP-2 activity [50,51], and SPARC expression was increased
89M.A. Horn et al. / Journal of Molecular and Cellular Cardiology 53 (2012) 82–90in the aged sheep LV, this could lead to further collagen degradation in
the aged failing myocardium.
4.4. Study limitations
While the data in the present manuscript clearly demonstrates the
inﬂuence of aging on cardiac remodeling and collagen content in HF,
we are unable to provide certain mechanical and functional informa-
tion e.g. compliance changes, cardiac output and E/A ratios. This is due
to the anatomical arrangement of the cardiac apex over the sternum
in the sheep preventing attainment of trans-thoracic four-chamber
apical views. We cannot discount the role of other determinants of
ventricular mechanics e.g. collagen cross-linking, collagen type I:III
ratio and titin isoform switches as playing a role in the divergent
age-dependent response to the induction of tachypacing-induced
HF. Furthermore, as the study has been carried out using only female
sheep, we cannot discount a possible role for estrogen in the results
reported, and thus differences which may be present in males.
4.5. Future directions
Further studies investigating the differences in myocardial me-
chanics in young and aged failing animals would build on the current
hypothesis. For example, performing conductance catheterization
post-pacing in both young and aged animals, would indicate whether
age-dependent changes to myocardial collagen content manifests as
divergent changes of myocardial stiffness/compliance and thus dete-
rioration of diastolic function. Additional techniques, such as MRI,
would be useful for calculating ejection fraction and myocardial
stress–strain relationships but are beyond the scope of the present
study.
4.6. Conclusions
The main conclusion from the present study is that age has a crit-
ically important impact on the response of the myocardium to a
disease-causing insult, in this case, tachypacing. As a consequence of
these observations we suggest that age should be considered both
in experimental cardiac research and in the development of thera-
peutic interventions aimed at correcting cardiac ECM remodeling in
heart disease.
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